Mismanagement

OMDAOmada Health, Inc.

Services-Health Services

Revenue
$260MFY2023: $123MFY2024: $170MFY2025: $260M
53% YoY
Operating margin
-4.6%FY2023: -53.8%FY2024: -25.7%FY2025: -4.6%
82% YoY
EBITDA
−$6MFY2023: −$62MFY2024: −$39MFY2025: −$6M
83% YoY
Market cap
—
Employees
—
Net debt / EBITDA
—
−$222M net debt
AI in 10-K
—

Red flags 0 of 9

Financials

MetricFY2023FY2024FY2025YoYTrend
Revenue$123M$170M$260M 53% FY2023: $123MFY2024: $170MFY2025: $260M
Operating income−$66M−$44M−$12M 73% FY2023: −$66MFY2024: −$44MFY2025: −$12M
Net income−$68M−$47M−$13M 73% FY2023: −$68MFY2024: −$47MFY2025: −$13M
Operating cash flow−$50M−$34M$18M 153% FY2023: −$50MFY2024: −$34MFY2025: $18M
Capex$416K$596K$1M 122% FY2023: $416KFY2024: $596KFY2025: $1M
Stock-based comp$9M$9M$13M 38% FY2023: $9MFY2024: $9MFY2025: $13M

Deal filings

None.

13D filers

None on file.

Insider trading

Open-market buys, 12 mo
$0 · 0
Open-market sells, 12 mo
$935K · 9
Net
−$935K

Pay vs performance

No pay-versus-performance disclosure yet.